Morphometric and histologic assessment of remodeling associated with restenosis after percutaneous transluminal coronary angioplasty

Cardiology

Volumn 90, Issue 2, 1998, Pages 115-121

  Nakamura, Yoichi ^a   Zhao, Hong ^b   Yutani, Chikao ^c   Imakita, Masami ^c   Ishibashi Ueda, Hatsue ^c  

^a OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adventitia; Neointima; Percutaneous transluminal coronary angioplasty; Remodeling; Restenosis

Indexed keywords

COLLAGEN FIBER;

ADVENTITIA; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CORONARY ARTERY SURGERY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTIMA; MALE; MORPHOMETRICS; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAUSE OF DEATH; CORONARY DISEASE; CORONARY VESSELS; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; RECURRENCE; TUNICA INTIMA;

EID: 0031734149     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006829     Document Type: Article

References (25)

1. Califf RM, Fortin DF, Frid DJ, Harlan WR III, Ohman EM, Bengtson JR, Nelson CL, Tcheng JE, Mark DB, Stack RS: Restenosis after coronary angioplaty: An overview. J Am Coll Cardiol 1991;17:2B-13B.
2. Serruys PW, Rutsch W, Heyndrickx GR, Danchin N, Mast EG, Wijns W, Rensing BJ, Vos J, Stibbe J: Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT). Circulation 1991;84: 1568-1580.
3. Ip JH, Fuster V, Israel D, Badimon L, Dadimon J, Chesebro JH: The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991; 17:77B-88B.
4. Muller DWM, Ellis SG, Topol EJ: Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1991;17:126B-131B.
5. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group: Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86:100-110.
6. Serruys PW, Klein W, Tijssen JPG, Rutsch W, Heyndrickx GR, Emanuelsson H, Ball SG, Decoster O, Schroeder E, Liberman H, Eichhorn E, Willerson JT, Anderson HV, Khaja F, Alexander RW, Baim D, Melkert R, van Oene JC, van Gool R: Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial. Circulation 1993;88(4 Pt 1):1588-1601.
7. Faxon DP, Spiro TE, Minor S, Coté G, Douglas J, Gottlieb R, Califf R, Dorosti K, Topol E, Gordon JB, Ohmen M, ERA Investigators: Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial. Circulation 1994;90:908-914.
8. Currier JW, Faxon DP: Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-520.
9. Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB: Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol 1994;74: 1278-1280.
10. Kimura T, Kaburagi S, Tamura T, Yokoi H, Nakagawa Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M, Mintz GS, Popma JJ, Leon MB: Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 1997;96:475-483.
11. Post MJ, Borst C, Kuntz RE: The relative importance of arterial remodeling compared with intimai hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994;89:2816-2821.
12. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM: Restenosis after experimental angioplasty. Intimal, medial and adventitial changes associated with constrictive remodeling. Circ Res 1995;76:996-1002.
13. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A: Adventitial remodeling after coronary arterial injury. Circulation 1996;93: 340-348.
14. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M: Serial angiopraphic follow-up after Palmaz-Schatz stent implantation: Comparison with conventional balloon angioplasty. J Am Coll Cardiol 1993;21:1557-1563.
15. Rodriguez AE, Santaera O, Larribau M, Fernandez M, Sarmiento R, Baliño NP, Newell JB, Roubin GS, Palacios IF: Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24 hours after successful PTCA. Circulation 1995;91:1397-1402.
16. Foley DP, Melkert R, Umans VA, DeJaegere PP, Strikwerda S, De Feyter PJ, Serruys PW: Differences in restenosis propensity of devices for transluminal coronary intervention: A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. Eur Heart J 1995;16:1331-1346.
17. Carrozza JP, Kuntz RK, Schatz RA, Leon M, Goldberg S, Savage M, Fishman D, Senerchia C, Diver DJ, Baim DS: Inter-series differences in the restenosis rate of Palmaz-Schatz coronary stent placement: Differences in demographics and post-procedure lumen diameter. Cathet Cardiovasc Diagn 1994;31:173-178.
18. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Clemen M, Heuser H, Almond D, Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Elus S, Rake R, Goldberg S: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331: 496-501.
19. Carrozza JP, Kuntz RE, Levine MJ, Pomerantz RM, Fishman RF, Mansour M, Gibson CM, Senerchia CC, Diver DJ, Safian RD, Baim DS: Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992;20:328-337.
20. Ellis SG, Savage M, Fishman D, Baim DS, Leon M, Goldberg S, Hirshfeld JW, Cleman MW, Teirstein PS, Walker C, Bailey S, Buchbinder M, Topol EJ, Schatz RA: Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 1992;86:1836-1844.
21. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF: Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-375.
22. Waller BF, Pinkerton CA, Foster LN: Morphologic evidence of accelerated left main coronary artery stenosis: A late complication of percutaneous transluminal balloon angioplasty of the proximal left anterior descending coronary artery. J Am Coll Cardiol 1987;9:1019-1023.
23. MacLeod DC, Strauss BH, DeJong M, Escaned J, Umans VA, VanSuylen RJ, Verkerk A, De Feyter PJ, Seurrys PW: Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol 1994; 23:59-65.
24. Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ: The three processes leading to post PTCA restenosis: Dependence on the lesion substrate. Thromb Haemost 1995; 74:552-559.
25. Waller BF, Pinkerton CA, Orr CM, Slack JD, VanTassel JW, Peters T: Morphological observations late (>30 days) after clinically successful coronary balloon angioplasty. Circulation 1991;83(suppl I):I-28-I-41.